Jean Wilson
Reviews 1

I had a great experience with a tech company recently. The website was user-friendly and had all the necessary information. The products were excellent, and I was impressed with the quality. I would highly recommend them to others!

Kristin Penny
Reviews 1

I recently had a great experience with a tech company. Their website was easy to navigate and had all the information I needed. The products they offered were top-notch and I was impressed with the quality. I would definitely recommend them to others!

Marc Green
Reviews 1

I had a great experience with a company recently. The website was easy to use and provided all the necessary information. The products were excellent, and I was impressed with the quality. I would highly recommend their services to others!

Kurt Wilkins
Reviews 1

Modigenetech is an amazing company! Their website is extremely user-friendly and visually appealing. Their products are of the highest quality and always deliver excellent results. I highly recommend them to anyone in need of their services.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="modigenetech" data-lang="en"></div>
More widgets

About Modigenetech

PROLOR Biotech is developing proprietary versions of already-approved therapeutic proteins. The Company’s Carboxyl Terminal Peptide technology can be attached to an array of existing therapeutic proteins, stabilizing the therapy in the bloodstream and extending its lifespan without additional toxicity or loss of desired biological activity. PROLOR products under development include Human Growth Hormone (“hGH”) for the long-term treatment of children and adults with growth failure due to inadequate secretion of endogenous growth hormone (a $3 billion market opportunity). PROLOR’s hGH could potentially be injected once a week or twice per month instead of daily. PROLOR’s hGH is scheduled for Phase III trials in 2013.

Categories
Biotechnology